Angiogenesis - Understanding the mathematical challenge

Angiogenesis

Volumn 9, Issue 3, 2006, Pages 127-138

  Jones, Pamela F ^a   Sleeman, Brian D ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiogenesis; Angiopoietins; Mathematical modelling; VEGF

Indexed keywords

ANGIOGENESIS; BIOCHEMISTRY; CAPILLARY; CELL FUNCTION; MATHEMATICAL MODEL; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; SCIENTIST; SIMULATION; SPROUTING;

ANGIOPOIETINS; ANIMALS; CAPILLARIES; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 33846894490     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-006-9039-8     Document Type: Review

References (38)

1. Anderson R, May RM (1979) Population biology of infectious diseases: Part I. Nature 280:361-367
2. Gewin V (2004) Disease control: virtual plagues get real. Nature 427:774-775
3. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
4. Patan S (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117:3-32
5. Gardiner CW (1983) Handbook of stochastic methods. Springer-Verlag
6. Stokes CL, Lauffenburger DA, Williams SK (1991) Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J Cell Sci 99:419-430
7. Stokes CL, Lauffenburger DA (1991) Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J Theor Biol 152:377-403
8. Chaplain MAJ, Anderson ARA (1999) Modelling the growth and form of capillary networks. In: Chaplain MAJ, Singh GD McLachlan JC (eds) On growth and form. Wiley, pp 225-249
9. McDougall SR, Anderson ARA, Chaplain MAJ, Sherratt JA (2002) Mathematical modelling of flow through vascular networks: implication for tumour induced angiogenesis and chemotherapy strategies. Bull Math Biol 24:673-702
10. Stéphanou A, McDougall SR, Anderson ARA, Chaplain MAJ (2005) Mathematical modelling of flow in 2D and 3D vascular networks: applications to anti-angiogenic and chemotherapeutic drug strategies. Math Comput Model 41:1137-1156
11. Pries AR, Secomb TW, Gaehtgens P (1998) Structural adaptation and stability of microvascular networks: theory and simulations. Am J Physiol 275:H349-360
12. Pries AR, Secomb TW (2003) Rheology of the microcirculation. Clin Hemorheol Microcirc 29:143-148
13. Levine HA, Pamuk S, Sleeman BD, Nilsen-Hamilton M (2001) Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma. Bull Math Biol 63:801-863
14. Alarcon T, Byrne HM, Maini PK (2003) A cellular automaton model for tumour growth in inhomogeneous environment. J Theor Biol 225:257-274
15. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676
16. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22
17. Costa C, Soares R, Schmitt F (2004) Angiogenesis: now and then. APMIS 112:402-412
18. Haas TL (2005) Endothelial cell regulation of matrix metalloproteinases. Can J Physiol Pharmacol 83:1-7
19. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253:269-285
20. Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9:267-285
21. Ingber DE (2002) Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 91:877-887
22. Gurdon JB, Dyson S, St Johnston D (1998) Cells' perception of position in a concentration gradient. Cell 95:159-162
23. Plank MJ, Sleeman BD (2003) A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies. Math Med Biol 20:135-181
24. Kendall RL, Rutledge RZ, Mao X, Tebben AJ, Hungate RW, Thomas KA (1999) Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J Biol Chem 274:6453-6460
25. Han ZC, Liu Y (1999) Angiogenesis: state of the art. Int J Haematol 70:68-82
26. Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53-65
27. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
28. Othmer HG, Stevens A (1997) Aggregation, blowup and collapse: the ABCs of taxis and reinforced random walks. SIAM J Appl Math 57:1044-1081
29. Plank MJ, Sleeman BD (2004) Lattice and non-lattice models of tumour angiogenesis. Bull Math Biol 66:1785-1819
30. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(Suppl 16):15-18
31. Jones PF (2003) Not just angiogenesis-wider roles for the angiopoietins. J Pathol 201:515-527
32. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169
33. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
34. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
35. Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362
36. Plank MJ, Sleeman BD, Jones PF (2004) The role of the angiopoietins in tumour angiogenesis. Growth Factors 22:1-11
37. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3:411-423
38. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2:727-739